Computational drug repositioning through heterogeneous network clustering

BMC Systems Biology

Volumn 7, Issue SUPPL 5, 2013, Pages

  Wu, Chao ^a,b   Gudivada, Ranga C ^c   Aronow, Bruce J ^a,b,d   Jegga, Anil G ^a,b,d  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b University of Cincinnati   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANILIDE; PROTEINASE INHIBITOR; PYRIDINE DERIVATIVE; SECRETASE; VISMODEGIB;

ALZHEIMER DISEASE; ARTICLE; BASAL CELL NEVUS SYNDROME; BIOLOGY; CLUSTER ANALYSIS; COMPUTER GRAPHICS; DRUG ANTAGONISM; DRUG REPOSITIONING; FACTUAL DATABASE; GENETICS; HUMAN; METHODOLOGY; PHENOTYPE; SUPPURATIVE HIDRADENITIS;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ANILIDES; BASAL CELL NEVUS SYNDROME; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; COMPUTER GRAPHICS; DATABASES, FACTUAL; DRUG REPOSITIONING; HIDRADENITIS SUPPURATIVA; HUMANS; PHENOTYPE; PROTEASE INHIBITORS; PYRIDINES;

EID: 84889655691     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-7-S5-S6     Document Type: Article

References (51)

1. Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 2004, 3(8):673-683. 10.1038/nrd1468, 15286734.
2. Boguski MS, Mandl KD, Sukhatme VP. Drug discovery. Repurposing with a difference. Science New York, NY 2009, 324(5933):1394-1395.
3. Pujol A, Mosca R, Farres J, Aloy P. Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol Sci 2010, 31(3):115-123. 10.1016/j.tips.2009.11.006, 20117850.
4. Sardana D, Zhu C, Zhang M, Gudivada RC, Yang L, Jegga AG. Drug repositioning for orphan diseases. Briefings in bioinformatics 2011, 12(4):346-356. 10.1093/bib/bbr021, 21504985.
5. Hurle MR, Yang L, Xie Q, Rajpal DK, Sanseau P, Agarwal P. Computational drug repositioning: from data to therapeutics. Clin Pharmacol Ther 2013, 93(4):335-341. 10.1038/clpt.2013.1, 23443757.
6. Iorio F, Bosotti R, Scacheri E, Belcastro V, Mithbaokar P, Ferriero R, Murino L, Tagliaferri R, Brunetti-Pierri N, Isacchi A, di Bernardo D. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci USA 2010, 107(33):14621-14626. 10.1073/pnas.1000138107, 2930479, 20679242.
7. Hu G, Agarwal P. Human Disease-Drug Network Based on Genomic Expression Profiles. PLoS ONE 2009, 4(8):e6536. 10.1371/journal.pone.0006536, 2715883, 19657382.
8. Sirota M, Dudley JT, Kim J, Chiang AP, Morgan AA, Sweet-Cordero A, Sage J, Butte AJ. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med 2011, 3(96):96ra77. 10.1126/scitranslmed.3001318, 3502016, 21849665.
9. Dudley JT, Sirota M, Shenoy M, Pai RK, Roedder S, Chiang AP, Morgan AA, Sarwal MM, Pasricha PJ, Butte AJ. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med 2011, 3(96):96ra76. 10.1126/scitranslmed.3002648, 3479650, 21849664.
10. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet J-P, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease. Science 2006, 313(5795):1929-1935. 10.1126/science.1132939, 17008526.
11. Iskar M, Zeller G, Blattmann P, Campillos M, Kuhn M, Kaminska KH, Runz H, Gavin AC, Pepperkok R, van Noort V, Bork P. Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding. Mol Syst Biol 2013, 9:662. 3658274, 23632384.
12. Pacini C, Iorio F, Goncalves E, Iskar M, Klabunde T, Bork P, Saez-Rodriguez J. DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data. Bioinformatics 2013, 29(1):132-134. 10.1093/bioinformatics/bts656, 3530913, 23129297.
13. Yang L, Agarwal P. Systematic Drug Repositioning Based on Clinical Side-Effects. PLoS ONE 2011, 6(12):e28025. 10.1371/journal.pone.0028025, 3244383, 22205936.
14. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P. Drug target identification using side-effect similarity. Science 2008, 321(5886):263-266. 10.1126/science.1158140, 18621671.
15. Duran-Frigola M, Aloy P. Recycling side-effects into clinical markers for drug repositioning. Genome Med 2012, 4(1):3. 10.1186/gm302, 3334551, 22283977.
16. Chiang AP, Butte AJ. Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clinical pharmacology and therapeutics 2009, 86(5):507-510. 10.1038/clpt.2009.103, 2836384, 19571805.
17. Cheng F, Liu C, Jiang J, Lu W, Li W, Liu G, Zhou W, Huang J, Tang Y. Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput Biol 2012, 8(5):e1002503. 10.1371/journal.pcbi.1002503, 3349722, 22589709.
18. Yutaka Fukuoka DT, Hisamichi O. A two-step drug repositioning method based on a protein-protein interaction network of genes shared by two diseases and the similarity of drugs. Bioinformation 2013, 9(2):89-93. 10.6026/97320630009089, 3563404, 23390352.
19. Assaf G, Gideon YS, Eytan R, Roded S. PREDICT: a method for inferring novel drug indications with application to personalized medicine. Molecular Systems Biology 2011, 7(1).
20. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, Whaley R, Glennon RA, Hert J, Thomas KL, Edwards DD, Shoichet BK, Roth BL. Predicting new molecular targets for known drugs. Nature 2009, 462(7270):175-181. 10.1038/nature08506, 2784146, 19881490.
21. Wu Z, Wang Y, Chen L. Network-based drug repositioning. Mol Biosyst 2013,
22. Lee HS, Bae T, Lee JH, Kim DG, Oh YS, Jang Y, Kim JT, Lee JJ, Innocenti A, Supuran CT, Chen L, Rho K, Kim S. Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug. BMC Syst Biol 2012, 6:80. 10.1186/1752-0509-6-80, 3443412, 22748168.
23. Dudley JT, Deshpande T, Butte AJ. Exploiting drug-disease relationships for computational drug repositioning. Briefings in Bioinformatics 2011, 12(4):303-311. 10.1093/bib/bbr013, 3137933, 21690101.
24. Suthram S, Dudley JT, Chiang AP, Chen R, Hastie TJ, Butte AJ. Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput Biol 2010, 6(2):e1000662. 10.1371/journal.pcbi.1000662, 2816673, 20140234.
25. Vincent DB, Jean-Loup G, Renaud L, Etienne L. Fast unfolding of communities in large networks. Journal of Statistical Mechanics: Theory and Experiment 2008, 2008(10):P10008.
26. Nepusz T, Yu H, Paccanaro A. Detecting overlapping protein complexes in protein-protein interaction networks. Nat Meth 2012, 9(5):471-472.
27. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Research 2010, 38(suppl 1):D355-D360. 2808910, 19880382.
28. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs. Nucleic Acids Research 2011, 39(suppl 1):D1035-D1041. 3013709, 21059682.
29. Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Research 2009, 37(suppl 2):W305-W311. 2703978, 19465376.
30. Bastian M, Heymann S, Jacomy M. Gephi: an open source software for exploring and manipulating networks. International AAAI Conference on Weblogs and Social Media: 2009 2009,
31. Srihari S, Leong HW. A survey of computational methods for protein complex prediction from protein interaction networks. Journal of Bioinformatics and Computational Biology 2013, 11(2):1230002. 10.1142/S021972001230002X, 23600810.
32. Van Landeghem S, De Bodt S, Drebert ZJ, Inzé D, Van de Peer Y. The Potential of Text Mining in Data Integration and Network Biology for Plant Research: A Case Study on Arabidopsis. The Plant Cell Online 2013,
33. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Research 2003, 13(11):2498-2504. 10.1101/gr.1239303, 403769, 14597658.
34. Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Research 2011, 39(suppl 1):D52-D57. 3013746, 21115458.
35. Madadhain J, Fisher D, Smyth P, Boey Y. Analysis and visualization of network data using JUNG. Journal of Statistical Software 2005, 10:1-35.
36. Yi{dotless}ldi{dotless}ri{dotless}m M, Goh K-I, Cusick M, Barabási A-L, Vidal M. Drug--target network. Nat Biotech 2007, 25(10):1119-1126.
37. Zhang M, Zhu C, Jacomy A, Lu LJ, Jegga AG. The orphan disease networks. Am J Hum Genet 2011, 88(6):755-766. 10.1016/j.ajhg.2011.05.006, 3113244, 21664998.
38. Fleuren WWM, Verhoeven S, Frijters R, Heupers B, Polman J, van Schaik R, de Vlieg J, Alkema W. CoPub update: CoPub 5.0 a text mining system to answer biological questions. Nucleic Acids Research 2011, 39(suppl 2):W450-W454. 3125746, 21622961.
39. Sayers E. E-utilities quick start 2008,
40. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Low JA, Mackey HM, Yauch RL, Graham RA, Reddy JC, Hauschild A. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012, 366(23):2171-2179. 10.1056/NEJMoa1113713, 22670903.
41. Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, Weiss GJ, Borad MJ, Hann CL, Brahmer JR, Mackey HM, Lum BL, Darbonne WC, Marsters JC, de Sauvage FJ, Low JA. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009, 361(12):1164-1172. 10.1056/NEJMoa0905360, 19726763.
42. Tang JY, Mackay-Wiggan JM, Aszterbaum M, Yauch RL, Lindgren J, Chang K, Coppola C, Chanana AM, Marji J, Bickers DR, Epstein EH. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 2012, 366(23):2180-2188. 10.1056/NEJMoa1113538, 22670904.
43. Eriksen JL, Sagi SA, Smith TE, Weggen S, Das P, McLendon DC, Ozols VV, Jessing KW, Zavitz KH, Koo EH, Golde TE. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J Clin Invest 2003, 112(3):440-449. 166298, 12897211.
44. Morihara T, Chu T, Ubeda O, Beech W, Cole GM. Selective inhibition of Abeta42 production by NSAID R-enantiomers. J Neurochem 2002, 83(4):1009-1012. 10.1046/j.1471-4159.2002.01195.x, 12421374.
45. Bateman RJ, Siemers ER, Mawuenyega KG, Wen G, Browning KR, Sigurdson WC, Yarasheski KE, Friedrich SW, Demattos RB, May PC, Paul SM, Holtzman DM. A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system. Ann Neurol 2009, 66(1):48-54. 10.1002/ana.21623, 2730994, 19360898.
46. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297(5580):353-356. 10.1126/science.1072994, 12130773.
47. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256(5054):184-185. 10.1126/science.1566067, 1566067.
48. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 1991, 6(4):487-498. 10.1016/0896-6273(91)90052-2, 1673054.
49. Kelleher RJ, Shen J. Genetics. Gamma-secretase and human disease. Science 2010, 330(6007):1055-1056. 10.1126/science.1198668, 21097925.
50. Wang B, Yang W, Wen W, Sun J, Su B, Liu B, Ma D, Lv D, Wen Y, Qu T, Chen M, Sun M, Shen Y, Zhang X. Gamma-secretase gene mutations in familial acne inversa. Science 2010, 330(6007):1065. 10.1126/science.1196284, 20929727.
51. Novac N. Challenges and opportunities of drug repositioning. Trends Pharmacol Sci 2013,